OXAGEN LTD innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United Kingdom	68
#2	WIPO (World Intellectual Property Organization)	22
#3	EPO (European Patent Office)	15
#4	Australia	11
#5	United States	11
#6	China	9
#7	Canada	8
#8	Brazil	6
#9	Republic of Korea	6
#10	Israel	5
#11	Mexico	5
#12	Norway	5
#13	New Zealand	5
#14	South Africa	5
#15	Ukraine	4
#16	Hong Kong	3
#17	Japan	2
#18	Morocco	1
#19	Serbia	1

#	Technology
#1	Therapeutic chemical compounds
#2	Heterocyclic compounds
#3	Medical preparations
#4	Measuring microorganism processes
#5	Building materials
#6	Analysing materials
#7	Peptides
#8	Animal care

#	Name	Total Patents
#1	Armer Richard Edward	55
#2	Boyd Edward Andrew	43
#3	Brookfield Frederick Arthur	32
#4	Wynne Graham Michael	31
#5	Pettipher Eric Roy	26
#6	Lovell James Matthew	20
#7	Middlemiss David	19
#8	Ashton Mark Richard	18
#9	Whittaker Mark	17
#10	Dorgan Colin Richard	15

Publication	Filing date	Title
GB201304055D0	2013-03-06	Polymorphic form
GB201304054D0	2013-03-06	Polymorphic form
GB201304053D0	2013-03-06	Polymorphic form
GB201222686D0	2012-12-17	Process
GB201203900D0	2012-03-06	Polymorphic form
GB201203906D0	2012-03-06	Polymorphic Form
GB201203914D0	2012-03-06	Polymorphic form
GB201121560D0	2011-12-15	Process
GB201121557D0	2011-12-15	Process
GB201120276D0	2011-11-24	Process
GB201103840D0	2011-03-07	Polymorphic form
GB201103838D0	2011-03-07	Polymorphic form
GB201103837D0	2011-03-07	Amorphous (5-Fluoro-2-Methyl-3-Quinolin-2-Ylmethyl-Indol-1-Yl)-acetic acid
GB201103839D0	2011-03-07	Polymorphic form
GB201012799D0	2010-07-30	Amorphous (5-fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-acetic acid
US2011124683A1	2010-05-13	Use of CRTH2 Antagonist Compounds
US2010063103A1	2009-11-24	Compounds having CRTH2 antagonist activity
GB0908729D0	2009-05-21	CRTH2 antagonists for treatment of infection in atopic subjects
WO2009093029A1	2009-01-22	Compounds having crth2 antagonist activity
EP2265581A1	2009-01-22	Compounds having crth2 antagonist activity